Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 17Neuroblastoma 13Glioblastoma 11Central Nervous System Neoplasms 9Ependymoma 8Brain Neoplasms 7Astrocytoma 7Medulloblastoma 6Osteosarcoma 5Oligodendroglioma 5Ganglioneuroblastoma 5Wilms Tumor 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Non-Hodgkin 4Histiocytosis, Langerhans-Cell 4Hepatoblastoma 4Gliosarcoma 4Sarcoma 3Rhabdomyosarcoma 3Lymphoma 3Glioma, Subependymal 3Breast Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Neurofibromatosis 1 2

Interventions

vorasidenib 1trametinib 1pamiparib 1interferon gamma-1b 1entrectinib 1dabrafenib 1cobimetinib 1capmatinib 1alectinib 1Vemurafenib 1Radiation 1Pemetrexed 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Biopsy × CNS × Clear all
NCT07416188 2026-06-05

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
40 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡